Inspire Medical Systems, Inc. (INSP) Earnings History
Annual and quarterly earnings data from 2016 to 2025
Loading earnings history...
INSP EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
INSP Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 85.4% | 5.6% | 15.9% |
| 2024 | 84.7% | 4.5% | 6.7% |
| 2023 | 84.5% | -6.4% | -3.4% |
| 2022 | 83.8% | -11.7% | -11.0% |
| 2021 | 85.7% | -17.1% | -18.0% |
Download Data
Export INSP earnings history in CSV or JSON format
Free sign-in required to download data
Inspire Medical Systems, Inc. (INSP) Earnings Overview
As of May 6, 2026, Inspire Medical Systems, Inc. (INSP) reported trailing twelve-month net income of $131M, reflecting +179.4% year-over-year growth. The company earned $4.57 per diluted share over the past four quarters, with a net profit margin of 15.9%.
Looking at the long-term picture, INSP's historical earnings data spans multiple years. The company achieved its highest annual net income of $145M in fiscal 2025, representing a new all-time high.
Inspire Medical Systems, Inc. maintains industry-leading profitability with a gross margin of 85.4%, operating margin of 5.6%, and net margin of 15.9%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including NVCR (-$173M net income, -20.8% margin), TNDM (-$205M net income, -20.2% margin), IRTC (-$28M net income, -6.0% margin), INSP has outperformed on profitability metrics. Compare INSP vs NVCR →
INSP Earnings vs Peers
Earnings metrics vs comparable public companies
INSP Historical Earnings Data (2016–2025)
10 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $145M | +171.8% | $51M | $4.89 | 15.9% | 5.6% |
| 2024 | $54M | +353.0% | $36M | $1.75 | 6.7% | 4.5% |
| 2023 | -$21M | +52.9% | -$40M | $-0.72 | -3.4% | -6.4% |
| 2022 | -$45M | -6.8% | -$48M | $-1.60 | -11.0% | -11.7% |
| 2021 | -$42M | +26.5% | -$40M | $-1.54 | -18.0% | -17.1% |
| 2020 | -$57M | -72.1% | -$56M | $-2.19 | -49.6% | -48.7% |
| 2019 | -$33M | -52.3% | -$35M | $-1.40 | -40.5% | -42.5% |
| 2018 | -$22M | -24.7% | -$20M | $-1.50 | -43.1% | -40.3% |
| 2017 | -$18M | +5.5% | -$16M | $-1.30 | -61.3% | -56.0% |
| 2016 | -$19M | - | -$17M | $-1.49 | -112.8% | -105.0% |
See INSP's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs INSP Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare INSP vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonINSP — Frequently Asked Questions
Quick answers to the most common questions about buying INSP stock.
Is INSP growing earnings?
INSP EPS is $4.57, with earnings growth accelerating to +179.4%. This exceeds the 5-year CAGR of N/A. TTM net income reached $131M.
What are INSP's profit margins?
Inspire Medical Systems, Inc. net margin is +15.9%, with operating margin at +5.6%. Above-average margins indicate pricing power.
How consistent are INSP's earnings?
INSP earnings data spans 2016-2025. The accelerating earnings trend is +179.4% YoY. Historical data enables comparison across business cycles.